Skip to main content
Quest Diagnostics

Flow Cytometry Assay Modifications: Recommendations for Method Validation Based on CLSI H62 Guidelines

Flow Cytometry Assay Modifications: Recommendations for Method Validation Based on CLSI H62 Guidelines

Authors: Monaghan SA, Eck S, Bunting S, Dong XX, Durso RJ, Gonneau C, Hays A, Illingworth A, League SC, Linskens E, McCausland M, McCloskey TW, Rolf N, Shi M, Wallace PK, Litwin V, Kern W, Deeb G, Nash V, Olteanu H

Citation: Cytometry B Clin Cytom. 2024 Aug 21. doi: 10.1002/cyto.b.22202. Online ahead of print.

Specialties: Laboratory medicine, Other

Related content

Audio Podcast
The power of laboratory analytics
Audio Podcast
Alternative Specimen Collection Options

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.